SmarterDividends
NVO

Novo Nordisk A/S

NVO

Healthcare · Stock · semiannual payer

$48.77

Undervalued · +47% Add to Portfolio

Forward Yield

3.74%

Annual Dividend

$1.80

Payout Ratio

43%

5-Yr Growth

20.9%

Ex-Date

Mar 30, 2026

Frequency

Semiannual

Summary

As of July 2026, Novo Nordisk A/S (NVO) yields 3.74% ($1.80 per share annually), with a blended fair-value estimate of $71.51 — +47% upside, so it screens as undervalued. Dividend safety grade: B (67/100). 7 years of dividend growth.

Is NVO a good dividend stock?

Yes, with caveats

Novo Nordisk A/S (NVO) pays a semiannual dividend yielding 3.74% ($1.80/yr), with 7 years of growth and a dividend-safety grade of B. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Comfortable payout ratio (43%)
  • Strong 20.9% 5-yr dividend growth

Risks

  • Cut its dividend in 2017
  • Share price is down over the past 5 years

Key Data

Dividend Yield
3.74%
Payout Ratio
43%
Annual Dividend
$1.80
5-Yr Avg Growth
20.9%
Ex-Dividend Date
Mar 30, 2026
Years of Growth
7
Frequency
semiannual
Beta
0.36
Market Cap
$215.7B
P/E Ratio
11.7
5-Yr Total Return
-2%
52-Week Range
$35.12 – $71.28
Dividend Safety
B · 67/100
Ever Cut?
Yes (2017)
NVO ex-dividend date & scheduleNext ex-date Mar 30, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $1.80 / yr per share

Per payment (semiannual)$90.00
Annual$180.00
Monthly avg$15.00